MAM
MDGL icon

Martingale Asset Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Martingale Asset Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.62M Buy
4,883
+398
+9% +$204K 0.06% 335
2026
Q1 		$2.35M Buy
4,485
+1,099
+32% +$525K 0.06% 308
2025
Q4 		$1.97M Sell
3,386
-1,129
-25% -$577K 0.05% 320
2025
Q3 		$2.07M Sell
4,515
-930
-17% -$347K 0.05% 306
2025
Q2 		$1.65M Sell
5,445
-99
-2% -$29.5K 0.04% 341
2025
Q1 		$1.84M Sell
5,544
-370
-6% -$122K 0.05% 317
2024
Q4 		$1.82M Buy
5,914
+150
+3% +$42.2K 0.04% 332
2024
Q3 		$1.22M Buy
+5,764
New +$1.47M 0.03% 416
2024
Q2 		– Sell
-6,163
Closed -$1.65M – 826
2024
Q1 		$1.65M Sell
6,163
-481
-7% -$113K 0.03% 346
2023
Q4 		$1.54M Buy
6,644
+661
+11% +$116K 0.03% 348
2023
Q3 		$874K Buy
5,983
+1,751
+41% +$330K 0.02% 474
2023
Q2 		$978K Buy
4,232
+100
+2% +$27.1K 0.02% 454
2023
Q1 		$1M Buy
+4,132
New +$1.13M 0.02% 442
2021
Q4 		– Sell
-5,404
Closed -$432K – 862
2021
Q3 		$432K Buy
5,404
+2,801
+108% +$242K 0.01% 693
2021
Q2 		$254K Buy
+2,603
New +$308K ﹤0.01% 752

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Martingale Asset Management's MDGL Position: Q2 2026 in Review

Martingale Asset Management increased its Madrigal Pharmaceuticals (MDGL) stake by 8.9% in Q2 2026, buying an estimated $204K and bringing the position to 4,883 shares worth $2.62M. The position accounts for 0.06% of the portfolio, ranked #335.

Martingale Asset Management first reported a position in MDGL in Q2 2021 and has held it in 15 quarters since. 413 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Martingale Asset Management held 4,883 shares of Madrigal Pharmaceuticals worth $2.62M as of Q2 2026.
  • Martingale Asset Management bought 398 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $204K.
  • Madrigal Pharmaceuticals made up 0.06% of Martingale Asset Management's portfolio in Q2 2026, its #335 holding.
  • Martingale Asset Management first reported a position in Madrigal Pharmaceuticals in Q2 2021 and has held it in 15 quarters since.
  • 413 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Martingale Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.